KELLY JARCZYK: Open Payments
NPI 1700039781 · SHAWNEE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 33 payments from 10 companies in 2025. Trend: 2023 $513 · 2024 $541 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 9 | $201 |
| SHIELD THERAPEUTICS INC | 3 | $186 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $93 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| MILLICENT US INC | 4 | $74 |
| Astellas Pharma US Inc | 3 | $61 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Organon LLC | 1 | $13 |
Products named: ZURZUVAE, ACCRUFER, MYFEMBREE, Veozah, FEMLYV, Exparel, UBRELVY, INTRAROSA.
Industry payments across KS — which companies pay providers there.
